Opinion|Videos|August 20, 2024
Patient Education, Provider Education, and Overall Final Thoughts
In this discussion, panelists offer their final thoughts.
Advertisement
Episodes in this series
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Sacituzumab Govitecan-hziy for First-Line Metastatic Triple-Negative Breast Cancer
2
CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes
3
More Potent and Tolerable, Azenosertib Advances as the Leading WEE1 Inhibitor
4
Clinicians Confront Fragmented Care and the Silent Burden of Undertreated Atopic Dermatitis
5